Never in my wildest dreams, would I have anticipated these Bio Counter Agents! This is amazing science, not to mention 5 mill from Merck last year and bout 4 mill guarranteed per each of the next 3+ years- "OUR TAX DOLLARS AT WORK- I think I will now do my TAXES!" Chucataxingapril15th-I am still...IN:
MERLIN's newly developed sister technology, VIRIA(TM), is designed to enable the discovery of molecules that bind to double-stranded RNA through the screening of combinatorial chemistry libraries. VIRIA has the potential to enable the construction of drugs targeted specifically to RNA viruses, which represent another class of possible biological warfare agents.
DARPA was established in 1958 to identify breakthrough ideas and technologies that provide radical new capabilities for solving critical military problems. DARPA is perhaps best known for its role in the development of ARPANET, the computer network technology upon which the Internet was based, as well as Stealth technology. DARPA supports projects that represent quantum leaps forward for technology by providing grants to both industry and academic institutions that have highly innovative ideas and potentially significant technologies with the goal of getting these ideas and technologies into practice.
''The purpose of the Unconventional Pathogen Countermeasures Program is to develop defensive technologies which afford the greatest protection to Department of Defense personnel during US military operations,'' stated Commander Shaun Jones, MD, Program Director. ''The genomics revolution is enabling the rapid identification and genomic sequencing of agents that could be used by malefactors for biological warfare. The availability of genetic sequences offers the possibility of taking entirely different and novel approaches to drug discovery. DARPA has sought out and is investing in innovative technologies that have the potential to provide significant advances in developing broad countermeasures to these biological agents. Genelabs' programs for creating gene-regulating drugs that function by binding to DNA or RNA fit these criteria well.''
Read it all but key into the above part ( 50% I scraped!):
To: +Joe Spiegel (113 )
From: +h.l. meeks Wednesday, Feb 11 1998 8:39AM EST
Reply # of 114
News: biz.yahoo.com
| Previous | ------ | Respond | YES ..please do...RESPOND: |
